从齐二药到欣弗事件,今年以来国内药企屡屡爆出丑闻,对于此现象,有人惊呼“我国GMP认证和管理中存在问题,导致药品生产企业到了问题集中爆发期”。面对行业诚信危机,药企该如何面对?民营药企行业要自律从齐二药事件到欣弗事件,公众、媒体都发出了这样的疑问,为什么通过了GMP(药 From the Qi two drugs to Yan Fu incident, since this year, domestic pharmaceutical companies repeatedly burst scandal, for this phenomenon, it was exclaimed, “China’s GMP certification and management problems, leading to drug manufacturers to focus on the outbreak of the problem.” The face of the industry crisis of honesty, how to face the pharmaceutical companies? Private pharmaceutical enterprises to self-discipline from the Qi two drugs incident to Yanver incident, the public, the media have sent such questions, why passed the GMP (medicine